Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Response to Comment.

Dufrost, Virginie; Risse, Jessie; Wahl, Denis; Zuily, Stéphane

Dufrost, Virginie; Risse, Jessie; Wahl, Denis; Zuily, Stéphane.

Afiliação

Dufrost V; Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, Nancy, France.
Risse J; Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, Nancy, France.
Wahl D; Inserm UMR_S 1116 at Lorraine University, Nancy, France.
Zuily S; Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, Nancy, France.

Curr Rheumatol Rep ; 19(8): 52, 2017 08.

Article em En | MEDLINE | ID: mdl-28741234

Assuntos

Síndrome Antifosfolipídica; Varfarina; Anticoagulantes; Humanos

Palavras-chave

Antiphospholipid antibodies; Antiphospholipid syndrome; Direct oral anticoagulants; Rivaroxaban; Thrombosis; Triple positivity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Varfarina / Síndrome Antifosfolipídica Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Revista: Curr Rheumatol Rep Assunto da revista: REUMATOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google